FTSJ1, FtsJ RNA 2'-O-methyltransferase 1, 24140

N. diseases: 57; N. variants: 0
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Mental Retardation, X-Linked Nonsyndromic
0.300 Biomarker disease CLINGEN Mutations in the FTSJ1 gene coding for a novel S-adenosylmethionine-binding protein cause nonsyndromic X-linked mental retardation. 15162322 2004
Mental Retardation, X-Linked Nonsyndromic
0.300 Biomarker disease CLINGEN A splice site mutation in the methyltransferase gene FTSJ1 in Xp11.23 is associated with non-syndromic mental retardation in a large Belgian family (MRX9). 15342698 2004
CUI: C3714756
Disease: Intellectual Disability
Intellectual Disability
0.070 GeneticVariation group BEFREE A splice site mutation in the methyltransferase gene FTSJ1 in Xp11.23 is associated with non-syndromic mental retardation in a large Belgian family (MRX9). 15342698 2004
CUI: C3714756
Disease: Intellectual Disability
Intellectual Disability
0.070 GeneticVariation group LHGDN A splice site mutation in the methyltransferase gene FTSJ1 in Xp11.23 is associated with non-syndromic mental retardation in a large Belgian family (MRX9). 15342698 2004
CUI: C0025362
Disease: Mental Retardation
Mental Retardation
0.030 GeneticVariation disease BEFREE A splice site mutation in the methyltransferase gene FTSJ1 in Xp11.23 is associated with non-syndromic mental retardation in a large Belgian family (MRX9). 15342698 2004
CUI: C1136249
Disease: Mental Retardation, X-Linked
Mental Retardation, X-Linked
0.030 GeneticVariation disease BEFREE Mutations in the FTSJ1 gene coding for a novel S-adenosylmethionine-binding protein cause nonsyndromic X-linked mental retardation. 15162322 2004
CUI: C1136249
Disease: Mental Retardation, X-Linked
Mental Retardation, X-Linked
0.030 GeneticVariation disease LHGDN Mutations in the FTSJ1 gene coding for a novel S-adenosylmethionine-binding protein cause nonsyndromic X-linked mental retardation. 15162322 2004
CUI: C0018378
Disease: Guillain-Barre Syndrome
Guillain-Barre Syndrome
0.010 Biomarker disease BEFREE These observations suggest that Spb1 contributes to the pathogenesis of neonatal GBS infection by mediating internalization of virulent serotype III GBS and confirm that understanding of the population structure of bacteria may lead to insights into the pathogenesis of human infections. 14638773 2003
CUI: C1269955
Disease: Tumor Cell Invasion
Tumor Cell Invasion
0.010 GeneticVariation phenotype BEFREE While adherence of the spb1 isogenic mutant to A549 respiratory, C2Bbe1 colonic, and HeLa cervical epithelial cells was slightly lower than that of the 874391 strain, invasion of the Spb1(-) mutant was significantly reduced with these cell lines compared to what was seen with 874391. 14638773 2003
CUI: C2020625
Disease: Group B Streptococcal Infection
Group B Streptococcal Infection
0.010 Biomarker disease BEFREE These observations suggest that Spb1 contributes to the pathogenesis of neonatal GBS infection by mediating internalization of virulent serotype III GBS and confirm that understanding of the population structure of bacteria may lead to insights into the pathogenesis of human infections. 14638773 2003
CUI: C4083008
Disease: Guillain-Barre Syndrome, Familial
Guillain-Barre Syndrome, Familial
0.010 Biomarker disease BEFREE These observations suggest that Spb1 contributes to the pathogenesis of neonatal GBS infection by mediating internalization of virulent serotype III GBS and confirm that understanding of the population structure of bacteria may lead to insights into the pathogenesis of human infections. 14638773 2003
CUI: C2931498
Disease: Mental Retardation, X-Linked 1
Mental Retardation, X-Linked 1
0.310 GeneticVariation disease BEFREE Family MRX9 revisited: further evidence for locus heterogeneity in MRX. 12239714 2002
Mental Retardation, X-Linked Nonsyndromic
0.300 Biomarker disease CLINGEN Family MRX9 revisited: further evidence for locus heterogeneity in MRX. 12239714 2002
Mental Retardation, X-Linked Nonsyndromic
0.300 Biomarker disease CLINGEN Four families (MRX43, MRX44, MRX45, MRX52) with nonspecific X-linked mental retardation: clinical and psychometric data and results of linkage analysis. 10398246 1999
Mental Retardation, X-Linked Nonsyndromic
0.300 Biomarker disease CLINGEN Localization of a gene responsible for nonspecific mental retardation (MRX9) to the pericentromeric region of the X chromosome. 8288232 1993
CUI: C0796215
Disease: Mental Retardation, X-Linked 9
Mental Retardation, X-Linked 9
0.500 Biomarker disease CTD_human
CUI: C0028754
Disease: Obesity
Obesity
0.110 Biomarker disease HPO
CUI: C0013132
Disease: Drooling
Drooling
0.100 Biomarker phenotype HPO
CUI: C0015469
Disease: Facial paralysis
Facial paralysis
0.100 Biomarker disease HPO
CUI: C0016202
Disease: Flatfoot
Flatfoot
0.100 Biomarker phenotype HPO
CUI: C0025037
Disease: Meckel Diverticulum
Meckel Diverticulum
0.100 Biomarker disease HPO
CUI: C0026106
Disease: Mild Mental Retardation
Mild Mental Retardation
0.100 Biomarker disease HPO
CUI: C0026351
Disease: Moderate intellectual disability
Moderate intellectual disability
0.100 Biomarker disease HPO
CUI: C0034194
Disease: Pyloric Stenosis
Pyloric Stenosis
0.100 Biomarker phenotype HPO
CUI: C0034935
Disease: Babinski Reflex
Babinski Reflex
0.100 Biomarker phenotype HPO